NFKB1 and diffuse large B-cell lymphoma: The current study shows that in diffuse large B- cell lymphoma (DLBCL) cells, LY2409881 inhibits the activated NFκB pathway, causing concentration- and time-dependent cell growth inhibition and apoptosis [18].